Cargando…

Effect of vitamin D on serum markers of bone turnover in SLE in a randomised controlled trial

OBJECTIVE: Bone health in SLE is adversely affected by vitamin D deficiency, inflammatory cytokines and glucocorticoid use. We hypothesised that vitamin D supplementation would increase markers of bone formation and decrease markers of bone resorption in SLE subjects. METHODS: We studied 43 vitamin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tedeschi, Sara K., Aranow, Cynthia, Kamen, Diane L., LeBoff, Meryl, Diamond, Betty, Costenbader, Karen H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6762038/ https://www.ncbi.nlm.nih.gov/pubmed/31592329 http://dx.doi.org/10.1136/lupus-2019-000352

Ejemplares similares

Osteoanabolic Agents for Osteoporosis
por: Haas, Andrea V, et al.
Publicado: (2018)

Selective dysregulation of the FcγIIB receptor on memory B cells in SLE
por: Mackay, Meggan, et al.
Publicado: (2006)

The Impact of Vitamin D on Dendritic Cell Function in Patients with Systemic Lupus Erythematosus
por: Ben-Zvi, Ilan, et al.
Publicado: (2010)

Protocol for virtual physical examination in an observational, longitudinal study evaluating virtual outcome measures in SLE
por: Askanase, Anca D, et al.
Publicado: (2023)

640. Prospective Association of Serum Vitamin D Level with Sepsis-Mortality in Postmenopausal Women: Results From the Women’s Health Initiative
por: Pinargote, Paulette, et al.
Publicado: (2018)

Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE
por: Anderson, Erik W, et al.
Publicado: (2022)

SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus
por: Costenbader, Karen H, et al.
Publicado: (2003)

VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population
por: LeBoff, Meryl S, et al.
Publicado: (2020)

Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance
por: Ploran, Elisabeth, et al.
Publicado: (2019)

Long-term anifrolumab safe in SLE
por: McHugh, Jessica
Publicado: (2023)

Effects of Supplemental Vitamin D on Bone Health Outcomes in Women and Men in the VITamin D and OmegA‐3 TriaL (VITAL)
por: LeBoff, Meryl S, et al.
Publicado: (2020)

SLE‐associated risk factors affect DC function
por: Son, Myoungsun, et al.
Publicado: (2015)

Brigham Fracture Intervention Team Initiatives for Hospital Patients with Hip Fractures: A Paradigm Shift
por: Glowacki, Julie, et al.
Publicado: (2010)

Association of Body Weight With Response to Vitamin D Supplementation and Metabolism
por: Tobias, Deirdre K., et al.
Publicado: (2023)

Effects of Vitamin D(3) Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL)
por: Chou, Sharon H, et al.
Publicado: (2021)

OA02.01. Effect of macronutrient composition of weight loss diets on reduction of the inflammatory marker hsCRP
por: Nicklas, J, et al.
Publicado: (2012)

Effect of Vitamin D(3) and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial
por: Orkaby, Ariela R., et al.
Publicado: (2022)

Phenotypic Characterization of Autoreactive B Cells—Checkpoints of B Cell Tolerance in Patients with Systemic Lupus Erythematosus
por: Jacobi, Annett M., et al.
Publicado: (2009)

Metabolomic Associations with Serum Bone Turnover Markers
por: Bellissimo, Moriah P., et al.
Publicado: (2020)

The Associations of Serum Vitamin D and Bone Turnover Markers with the Type and Severity of Hip Fractures in Older Women
por: Zhao, Jinhui, et al.
Publicado: (2020)

SARS-CoV-2 vaccines in patients with SLE
por: Tang, Wei, et al.
Publicado: (2021)

Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis
por: Choi, May Y, et al.
Publicado: (2020)

Effect of Dietary Composition of Weight Loss Diets on High Sensitivity C-Reactive Protein: The Randomized POUNDS LOST Trial
por: Nicklas, Jacinda M., et al.
Publicado: (2013)

Jaccoud’s arthropathy in SLE: findings from a Latin American multiethnic population
por: Quintana, Rosana, et al.
Publicado: (2019)

Complement Inhibition in the Treatment of SLE-Associated Thrombotic Thrombocytopenic Purpura
por: Boneparth, Alexis, et al.
Publicado: (2015)

Predictors of peripheral arterial disease in SLE change with patient’s age
por: Erdozain, Jose-Gabriel, et al.
Publicado: (2017)

LLDAS is an attainable treat-to-target goal in childhood-onset SLE
por: Wahadat, Mohamed Javad, et al.
Publicado: (2021)

Short-term effects of teriparatide versus placebo on bone biomarkers, structure, and fracture healing in women with lower-extremity stress fractures: A pilot study
por: Almirol, Ellen A., et al.
Publicado: (2016)

Persistent expression of autoantibodies in SLE patients in remission
por: Yurasov, Sergey, et al.
Publicado: (2006)

L-sepiapterin restores SLE serum-induced markers of endothelial function in endothelial cells
por: Jones Buie, Joy N, et al.
Publicado: (2019)

Cell-bound complement activation products associate with lupus severity in SLE
por: Arriens, Cristina, et al.
Publicado: (2020)

DNA-Mediated Interferon Signature Induction by SLE Serum Occurs in Monocytes Through Two Pathways: A Mechanism to Inhibit Both Pathways
por: Porat, Amit, et al.
Publicado: (2018)

Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression
por: Son, Myoungsun, et al.
Publicado: (2017)

Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study
por: Morand, Eric F, et al.
Publicado: (2020)

Effect of pregnancy on serum cytokines in SLE patients
por: Doria, Andrea, et al.
Publicado: (2012)

SLE and Serum Complement: Causative, Concomitant or Coincidental?
por: Sandhu, Vaneet, et al.
Publicado: (2017)

SLE and Serum Complement: Causative, Concomitant or Coincidental?
por: Sandhu, Vaneet, et al.
Publicado: (2018)

Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire
por: Gray, Daniel, et al.
Publicado: (2007)

Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
por: Kolben, Thomas, et al.
Publicado: (2022)

Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis
por: Birt, Julie A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7so3jghreavn92m812bi2dfgev